论文信息 - ClarIDHy: A global, phase III, randomized, double-blind study of ivosidenib (IVO) vs placebo in patients with advanced cholangiocarcinoma (CC) with an isocitrate dehydrogenase 1 (IDH1) mutation - 字舞流文

ClarIDHy: A global, phase III, randomized, double-blind study of ivosidenib (IVO) vs placebo in patients with advanced cholangiocarcinoma (CC) with an isocitrate dehydrogenase 1 (IDH1) mutation

A. Zhu | M. Borad | G. Abou-Alfa | J. Bridgewater | J. Valle | D. Oh | M. Javle | S. Lubner | W. Harris | J. Whisenant | S. Pandya | D. Catenacci | C. Gliser | J. Adeva | J. Cleary | A. Murphy | T. M. Mercadé | Liewen Jiang | Camelia Gliser | R. K. Kelley | Bin Wu | R. Kelley